Many With Nonceliac Wheat Sensitivity Have Autoimmune Dz

This article originally appeared here.
Share this content:
Many With Nonceliac Wheat Sensitivity Have Autoimmune Dz
Many With Nonceliac Wheat Sensitivity Have Autoimmune Dz

THURSDAY, Aug. 27, 2015 (HealthDay News) -- More patients with nonceliac wheat sensitivity (NCWS) and celiac disease (CD) than irritable bowel syndrome (IBS) develop autoimmune diseases (ADs), according to a study published in the September issue of Gastroenterology.

Antonio Carroccio, M.D., from the University of Palermo in Italy, and colleagues conducted a retrospective study of 131 patients with NCWS and 151 control patients with CD and IBS to examine the prevalence of AD and antinuclear antibodies (ANA). A prospective study was conducted involving 42 patients with NCWS and 100 age- and sex-matched controls with CD or IBS.

The researchers found that 29 percent of patients with NCWS and CD developed ADs (mainly Hashimoto's thyroiditis) compared to 4 percent of patients with IBS (P < 0.001). In the prospective study, 24, 20, and 2 percent, respectively, developed ADs (P < 0.001). Serum samples tested positive for ANA in 46, 24, and 2 percent of samples with NCWS, CD, and IBS, respectively (P < 0.001 for CD and IBS versus NCWS), in the retrospective study. The corresponding values in the prospective study were 28, 7.5, and 6 percent (P = 0.02 for CD and P = 0.005 for IBS versus NCWS).

"Higher proportions of patients with NCWS or CD develop autoimmune disorders, are ANA positive, and showed DQ2/DQ8 haplotypes compared with patients with IBS," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »